Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results

author
created [InstanceEdit:9845200] Stephan, Ralf, 2023-09-28
dbId 9845208
displayName Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results
journal PLoS One
modified [InstanceEdit:9851834] Stephan, Ralf, 2023-11-01
pages e0288271
pubMedIdentifier 37467213
schemaClass LiteratureReference
title Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results
url http://www.ncbi.nlm.nih.gov/pubmed/37467213
volume 18
year 2023
Cite Us!